ITW
67
3
PVH
58
4
MMM
52
-5
EIX
74
2
AAP
33
4
NTRS
40
-4
BWA
56
3
MU
48
-4
BXP
59
2
PEG
74
2
CPB
55
-2
TJX
51
-3
HBAN
47
2
MRO
42
-5
CME
50
-8
GT
56
5
CHK
64
9
FOX
42
2
NFLX
55
-2
AIV
68
-2
ITW
67
3
PVH
58
4
MMM
52
-5
EIX
74
2
AAP
33
4
NTRS
40
-4
BWA
56
3
MU
48
-4
BXP
59
2
PEG
74
2
CPB
55
-2
TJX
51
-3
HBAN
47
2
MRO
42
-5
CME
50
-8
GT
56
5
CHK
64
9
FOX
42
2
NFLX
55
-2
AIV
68
-2
Financhill
Back

Nuveen S&P 500 Dynamic Overwrite Fund Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
32

SPXX
Nuveen S&P 500 Dynamic Overwrite Fund

Last Price:
16.58
Seasonality Move:
0.69%
Sell
36

SRPT
Sarepta Therapeutics

Last Price:
124.65
Seasonality Move:
-1.39%
Sell
32
Nuveen S&P 500 Dynamic Overwrite Fund (SPXX) is a Sell

Is Nuveen S&P 500 Dynamic Overwrite Fund a Buy, Sell or Hold?

  • The current Nuveen S&P 500 Dynamic Overwrite Fund [SPXX] share price is $16.61. The Score for SPXX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • SPXX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $124.53. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SPXX Stock Price Chart

What is Nuveen S&P 500 Dynamic Overwrite Fund's stock price today?

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $124.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.

SPXX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.06 Buy
Relative Strength Index (14 RSI): 56.71 Buy
Chaikin Money Flow: 5438 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.4 - 16.64) Buy
Bollinger Bands (100): (15.86 - 16.54) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.18 Sell
Relative Strength Index (14 RSI): 35.54 Sell
Chaikin Money Flow: -49995 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (124.27 - 135.95) Sell
Bollinger Bands (100): (123.89 - 147.49) Sell

SPXX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 16.55 Buy
20-day SMA: 16.49 Buy
50-day SMA: 16.33 Buy
200-day SMA: 15.73 Buy
8-day EMA: 16.56 Buy
20-day EMA: 16.51 Buy
50-day EMA: 16.38 Buy
200-day EMA: 15.89 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 125.45 Sell
20-day SMA: 127.75 Sell
50-day SMA: 135.2 Sell
200-day SMA: 127.53 Sell
8-day EMA: 125.39 Sell
20-day EMA: 128.04 Sell
50-day EMA: 132.59 Sell
200-day EMA: 128.64 Sell

Nuveen S&P 500 Dynamic Overwrite Fund Earnings Growth & SPXX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $2.81 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.

Nuveen S&P 500 Dynamic Overwrite Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):